. Author manuscript; available in PMC: 2024 Aug 12.

Published in final edited form as: Hosp Pediatr. 2023 Dec 1;13(12):1115–1123. doi: 10.1542/hpeds.2023-007273

TABLE 2.

Prevalence of Provider-Selected GIP Order Indications

	All Encounters, N = 1124	Non-CCC, N = 512	CCC, N = 612	P
Diarrhea with blood or pus	185 (16.5%)	106 (20.7%)	79 (12.9%)	<.001
Concern for C. difficile	169 (15.0%)	50 (9.8%)	119 (19.4%)	<.001
Prolonged diarrhea (>7 d)	137 (12.2%)	79 (15.4%)	58 (9.5%)	.002
Severe water-loss diarrhea/dehydration	229 (20.4%)	109 (21.3%)	120 (19.6%)	.49
Hemolytic uremic syndrome	8 (0.7%)	6 (1.2%)	2 (0.3%)	.15
International travel-associated diarrhea	19 (1.7%)	18 (3.5%)	1 (0.2%)	<.001
Epidemiologic/surveillance testing	67 (6.0%)	19 (3.7%)	48 (7.8%)	.004
Other	310 (27.6%)	125 (24.4%)	185 (30.2%)	.030

Values are displayed as N (%) where N represents the number of GIP tests. P values from Pearson’s χ² test (or Fisher’s exact).